Brought to you by 
Respironics buys Novametrix for $90mm in stock
17 Jun 2013
Executive Summary
Respironics (cardiorespiratory ventilators) will acquire Novametrix (cardiac and respiratory monitoring devices) in a tax-free stock swap valued at $90mm, or $8.65 per share to Novametrix (based on Respironics' share price of $34.59), including the assumption of about $6mm in debt. An exact exchange ratio will be based on Respironics' average trading price over a specified period, and is subject to a collar.
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Respironics buys Novametrix for $90mm in stock
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice